PRESS RELEASEAB SCIENCE WILL HOST A LIVE WEBCAST ON TUESDAY JANUARY 28, 2025 FROM 5.30PM TO 6.45PM CETParis, 24 January 2025, 6pm CETAB Science SA (Euronext - FR0010557264 - AB) will host a live webcast on Tuesday January 28, 2025, from 5.30pm to 6.45pm CET.The agenda of this live webcast will be to provide an update on masitinib platform.The following attendees will participate to the live webcast:Alain Moussy, co-founder and CEO of AB ScienceOlivier Hermine, MD, PhD, Head of the Hematological department at the Necker-Enfants Malades hospital, Paris, FranceWebcast InformationWebcast date: Tuesday January 28, 2025. US: 11.30am-12.45pm ET; Europe: 5.30pm-6.45pm CETZOOM link to the webcast (audio + presentation): Access to the webcastAbout AB ScienceFounded in 2001, AB Science is a pharmaceutical company specializing in the research, development and commercialization of protein kinase inhibitors (PKIs), a class of targeted proteins whose action ...Full story available on Benzinga.com
AB Science is a France-based pharmaceutical company that researches and develops novel therapeutics for the treatment of cancer, inflammatory and neurodegenerative disorders.